Sections
| Title | Starting Page | Number of Pages |
|---|
| Cover Page | 1 | 1 |
| List of Contents and Tables | 2 | 1 |
| MARKET INDICATORS | 2 | 1 |
| Analgesics in Egypt - Category Analysis | 2 | 1 |
| 2025 DEVELOPMENTS | 2 | 1 |
| PROSPECTS and OPPORTUNITIES | 2 | 1 |
| Table/Chart: 3 | 2 | 1 |
| Table/Chart: Tabular Data Analysis | 2 | 1 |
| Table/Chart: CATEGORY DATA | 2 | 1 |
| PROSPECTS and OPPORTUNITIES | 3 | 1 |
| CATEGORY DATA | 3 | 1 |
| Cough, Cold and Allergy (Hay Fever) Remedies in Egypt - Category Analysis | 3 | 1 |
| KEY DATA FINDINGS | 3 | 1 |
| Dermatologicals in Egypt - Category Analysis | 3 | 1 |
| Table/Chart: Table 17 Sales of Sleep Aids: Value 2020-2025 | 3 | 1 |
| Table/Chart: Tabular Data Analysis | 3 | 1 |
| Table/Chart: 26 | 3 | 1 |
| CONSUMER HEALTH IN EGYPT | 4 | 1 |
| NRT Smoking Cessation Aids in Egypt - Category Analysis | 4 | 1 |
| Wound Care in Egypt - Category Analysis | 4 | 1 |
| Table/Chart: Tabular Data Analysis | 4 | 1 |
| CONSUMER HEALTH IN EGYPT | 5 | 1 |
| PROSPECTS and OPPORTUNITIES | 5 | 1 |
| CATEGORY DATA | 5 | 1 |
| Table/Chart: 51 | 5 | 1 |
| Table/Chart: Tabular Data Analysis | 5 | 1 |
| CONSUMER HEALTH IN EGYPT | 6 | 1 |
| Weight Management and Wellbeing in Egypt - Category Analysis | 6 | 1 |
| Table/Chart: 65 | 6 | 1 |
| Table/Chart: Tabular Data Analysis | 6 | 1 |
| Table/Chart: CATEGORY DATA | 6 | 1 |
| CONSUMER HEALTH IN EGYPT | 7 | 1 |
| Table/Chart: Tabular Data Analysis | 7 | 1 |
| Consumer Health in Egypt - Industry Overview | 8 | 1 |
| EXECUTIVE SUMMARY | 8 | 1 |
| Key trends in 2025 | 8 | 1 |
| Competitive landscape | 8 | 1 |
| CONSUMER HEALTH IN EGYPT | 9 | 1 |
| Channel developments | 9 | 1 |
| What next for consumer health? | 9 | 1 |
| MARKET INDICATORS | 9 | 1 |
| CONSUMER HEALTH IN EGYPT | 10 | 1 |
| MARKET DATA | 10 | 1 |
| Table 4 Sales of Consumer Health by Category: % Value Growth 2020-2025 | 10 | 1 |
| Table/Chart: Tabular Data Analysis | 10 | 1 |
| Table/Chart: Table 2 Life Expectancy at Birth 2020-2025 | 10 | 1 |
| Table/Chart: EGP million | 10 | 1 |
| Table/Chart: % current value growth | 10 | 1 |
| CONSUMER HEALTH IN EGYPT | 11 | 1 |
| Table/Chart: Tabular Data Analysis | 11 | 1 |
| Table/Chart: Table 5 NBO Company Shares of Consumer Health: % Value 2021-2025 | 11 | 1 |
| CONSUMER HEALTH IN EGYPT | 12 | 1 |
| Table/Chart: Tabular Data Analysis | 12 | 1 |
| Table/Chart: Table 6 LBN Brand Shares of Consumer Health: % Value 2022-2025 | 12 | 1 |
| CONSUMER HEALTH IN EGYPT | 13 | 1 |
| Table 7 Distribution of Consumer Health by Format: % Value 2020-2025 | 13 | 1 |
| Table/Chart: Tabular Data Analysis | 13 | 1 |
| Table/Chart: % retail value rsp | 13 | 1 |
| CONSUMER HEALTH IN EGYPT | 14 | 1 |
| Table/Chart: Table 8 Distribution of Consumer Health by Format and Category: % Value 2025 | 14 | 1 |
| Table/Chart: Tabular Data Analysis | 14 | 1 |
| CONSUMER HEALTH IN EGYPT | 15 | 1 |
| Table 9 Forecast Sales of Consumer Health by Category: Value 2025-2030 | 15 | 1 |
| EGP million | 15 | 1 |
| Table/Chart: Tabular Data Analysis | 15 | 1 |
| CONSUMER HEALTH IN EGYPT | 16 | 1 |
| Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030 | 16 | 1 |
| APPENDIX | 16 | 1 |
| Otc registration and classification | 16 | 1 |
| Table/Chart: % constant value growth | 16 | 1 |
| Table/Chart: Tabular Data Analysis | 16 | 1 |
| CONSUMER HEALTH IN EGYPT | 17 | 1 |
| Vitamins and dietary supplements registration and classification | 17 | 1 |
| Disclosure | 18 | 1 |
| Disclosure | 19 | 1 |
| Table/Chart: Summary 1 Research Sources | 19 | 1 |
| Table/Chart: Tabular Data Analysis | 19 | 1 |
| Disclosure | 20 | 1 |
| Disclosure | 21 | 1 |
| Disclosure | 22 | 1 |
| Table/Chart: EGP million | 22 | 1 |
| Table/Chart: Tabular Data Analysis | 22 | 1 |
| Table/Chart: % current value growth | 22 | 1 |
| Disclosure | 23 | 1 |
| Table/Chart: Tabular Data Analysis | 23 | 1 |
| Table/Chart: Table 13 NBO Company Shares of Analgesics: % Value 2021-2025 | 23 | 1 |
| Disclosure | 24 | 1 |
| Table/Chart: Tabular Data Analysis | 24 | 1 |
| Table/Chart: Table 14 LBN Brand Shares of Analgesics: % Value 2022-2025 | 24 | 1 |
| Disclosure | 25 | 1 |
| Table/Chart: Tabular Data Analysis | 25 | 1 |
| Table/Chart: Table 15 Forecast Sales of Analgesics by Category: Value 2025-2030 | 25 | 1 |
| Disclosure | 26 | 1 |
| Table/Chart: Tabular Data Analysis | 26 | 1 |
| Table/Chart: Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030 | 26 | 1 |
| Disclosure | 27 | 1 |
| Disclosure | 28 | 1 |
| Disclosure | 29 | 1 |
| Table/Chart: EGP million | 29 | 1 |
| Table/Chart: Tabular Data Analysis | 29 | 1 |
| Table/Chart: Table 18 Sales of Sleep Aids: % Value Growth 2020-2025 | 29 | 1 |
| Table/Chart: Table 19 NBO Company Shares of Sleep Aids: % Value 2021-2025 | 29 | 1 |
| Table/Chart: Table 20 LBN Brand Shares of Sleep Aids: % Value 2022-2025 | 29 | 1 |
| Disclosure | 30 | 1 |
| Graph - Graph/Chart Analysis | 30 | 1 |
| Table/Chart: Tabular Data Analysis | 30 | 1 |
| Table/Chart: EGP million | 30 | 1 |
| Table/Chart: % constant value growth | 30 | 1 |
| Disclosure | 31 | 1 |
| Disclosure | 32 | 1 |
| Disclosure | 33 | 1 |
| Table/Chart: EGP million | 33 | 1 |
| Table/Chart: Tabular Data Analysis | 33 | 1 |
| Table/Chart: % current value growth | 33 | 1 |
| Disclosure | 34 | 1 |
| Table/Chart: Table 25 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021- 2025 | 34 | 1 |
| Table/Chart: Tabular Data Analysis | 34 | 1 |
| Disclosure | 35 | 1 |
| Graph - Industries | 35 | 1 |
| Table/Chart: Table 26 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2022-2025 | 35 | 1 |
| Table/Chart: Tabular Data Analysis | 35 | 1 |
| Disclosure | 36 | 1 |
| Table/Chart: Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2025-2030 | 36 | 1 |
| Table/Chart: Tabular Data Analysis | 36 | 1 |
| Table/Chart: % constant value growth | 36 | 1 |
| Disclosure | 37 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 37 | 1 |
| Table/Chart: Tabular Data Analysis | 37 | 1 |
| Disclosure | 38 | 1 |
| Disclosure | 39 | 1 |
| Disclosure | 40 | 1 |
| Table/Chart: EGP million | 40 | 1 |
| Table/Chart: Tabular Data Analysis | 40 | 1 |
| Table/Chart: % current value growth | 40 | 1 |
| Disclosure | 41 | 1 |
| Table/Chart: Tabular Data Analysis | 41 | 1 |
| Table/Chart: Table 32 LBN Brand Shares of Dermatologicals: % Value 2022-2025 | 41 | 1 |
| Disclosure | 42 | 1 |
| Table/Chart: Tabular Data Analysis | 42 | 1 |
| Disclosure | 43 | 1 |
| Table/Chart: Tabular Data Analysis | 43 | 1 |
| Table/Chart: Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2022-2025 | 43 | 1 |
| Table/Chart: Table 34 Forecast Sales of Dermatologicals by Category: Value 2025-2030 | 43 | 1 |
| Disclosure | 44 | 1 |
| Graph - Graph/Chart Analysis | 44 | 1 |
| Table/Chart: % constant value growth | 44 | 1 |
| Table/Chart: Tabular Data Analysis | 44 | 1 |
| Disclosure | 45 | 1 |
| Disclosure | 46 | 1 |
| Disclosure | 47 | 1 |
| Table/Chart: EGP million | 47 | 1 |
| Table/Chart: Tabular Data Analysis | 47 | 1 |
| Table/Chart: % current value growth | 47 | 1 |
| Disclosure | 48 | 1 |
| Table/Chart: Table 38 NBO Company Shares of Digestive Remedies: % Value 2021-2025 | 48 | 1 |
| Table/Chart: Tabular Data Analysis | 48 | 1 |
| Disclosure | 49 | 1 |
| Table/Chart: Table 39 LBN Brand Shares of Digestive Remedies: % Value 2022-2025 | 49 | 1 |
| Table/Chart: Tabular Data Analysis | 49 | 1 |
| Disclosure | 50 | 1 |
| Table/Chart: EGP million | 50 | 1 |
| Table/Chart: Tabular Data Analysis | 50 | 1 |
| Table/Chart: % constant value growth | 50 | 1 |
| Disclosure | 51 | 1 |
| Graph - Graph/Chart Analysis | 51 | 1 |
| Disclosure | 52 | 1 |
| Disclosure | 53 | 1 |
| Disclosure | 54 | 1 |
| Table/Chart: EGP million | 54 | 1 |
| Table/Chart: Tabular Data Analysis | 54 | 1 |
| Table/Chart: % current value growth | 54 | 1 |
| Table/Chart: Table 44 NBO Company Shares of Eye Care: % Value 2021-2025 | 54 | 1 |
| Table/Chart: Table 45 LBN Brand Shares of Eye Care: % Value 2022-2025 | 54 | 1 |
| Disclosure | 55 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 55 | 1 |
| Table/Chart: Tabular Data Analysis | 55 | 1 |
| Table/Chart: EGP million | 55 | 1 |
| Table/Chart: % constant value growth | 55 | 1 |
| Disclosure | 56 | 1 |
| Graph - Nrt smoking cessation aids remain marginal, with limited growth prospects | 56 | 1 |
| Disclosure | 57 | 1 |
| Disclosure | 58 | 1 |
| Disclosure | 59 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 59 | 1 |
| Table/Chart: Tabular Data Analysis | 59 | 1 |
| Disclosure | 60 | 1 |
| Table/Chart: % current value growth | 60 | 1 |
| Table/Chart: Tabular Data Analysis | 60 | 1 |
| Table/Chart: Table 50 NBO Company Shares of Wound Care: % Value 2021-2025 | 60 | 1 |
| Table/Chart: Table 51 LBN Brand Shares of Wound Care: % Value 2022-2025 | 60 | 1 |
| Disclosure | 61 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 61 | 1 |
| Table/Chart: EGP million | 61 | 1 |
| Table/Chart: Tabular Data Analysis | 61 | 1 |
| Table/Chart: Table 53 Forecast Sales of Wound Care by Category: % Value Growth 2025-2030 | 61 | 1 |
| Disclosure | 62 | 1 |
| Disclosure | 63 | 1 |
| Disclosure | 64 | 1 |
| Table/Chart: Tabular Data Analysis | 64 | 1 |
| Table/Chart: % current value growth | 64 | 1 |
| Table/Chart: Table 56 NBO Company Shares of Sports Nutrition: % Value 2021-2025 | 64 | 1 |
| Table/Chart: Table 57 LBN Brand Shares of Sports Nutrition: % Value 2022-2025 | 64 | 1 |
| Disclosure | 65 | 1 |
| Table/Chart: Tabular Data Analysis | 65 | 1 |
| Table/Chart: EGP million | 65 | 1 |
| Table/Chart: % constant value growth | 65 | 1 |
| Disclosure | 66 | 1 |
| Disclosure | 67 | 1 |
| Disclosure | 68 | 1 |
| Table/Chart: EGP million | 68 | 1 |
| Table/Chart: Tabular Data Analysis | 68 | 1 |
| Table/Chart: Table 61 Sales of Dietary Supplements by Category: % Value Growth 2020-2025 | 68 | 1 |
| Disclosure | 69 | 1 |
| Table/Chart: Tabular Data Analysis | 69 | 1 |
| Table/Chart: Table 62 Sales of Dietary Supplements by Positioning: % Value 2020-2025 | 69 | 1 |
| Table/Chart: Table 63 NBO Company Shares of Dietary Supplements: % Value 2021-2025 | 69 | 1 |
| Disclosure | 70 | 1 |
| Table/Chart: Tabular Data Analysis | 70 | 1 |
| Table/Chart: Table 64 LBN Brand Shares of Dietary Supplements: % Value 2022-2025 | 70 | 1 |
| Disclosure | 71 | 1 |
| Table/Chart: Tabular Data Analysis | 71 | 1 |
| Table/Chart: Table 65 Forecast Sales of Dietary Supplements by Category: Value 2025-2030 | 71 | 1 |
| Disclosure | 72 | 1 |
| Table/Chart: Tabular Data Analysis | 72 | 1 |
| Table/Chart: % constant value growth | 72 | 1 |
| Disclosure | 73 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 73 | 1 |
| Table/Chart: Tabular Data Analysis | 73 | 1 |
| Disclosure | 74 | 1 |
| Disclosure | 75 | 1 |
| Disclosure | 76 | 1 |
| Table/Chart: Tabular Data Analysis | 76 | 1 |
| Table/Chart: % current value growth | 76 | 1 |
| Table/Chart: % retail value rsp | 76 | 1 |
| Table/Chart: Table 70 NBO Company Shares of Vitamins: % Value 2021-2025 | 76 | 1 |
| Disclosure | 77 | 1 |
| Table/Chart: Tabular Data Analysis | 77 | 1 |
| Table/Chart: Table 71 LBN Brand Shares of Vitamins: % Value 2022-2025 | 77 | 1 |
| Disclosure | 78 | 1 |
| Table/Chart: Tabular Data Analysis | 78 | 1 |
| Table/Chart: Table 72 Forecast Sales of Vitamins by Category: Value 2025-2030 | 78 | 1 |
| Disclosure | 79 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 79 | 1 |
| Table/Chart: Tabular Data Analysis | 79 | 1 |
| Disclosure | 80 | 1 |
| Disclosure | 81 | 1 |
| Table/Chart: EGP million | 81 | 1 |
| Table/Chart: Tabular Data Analysis | 81 | 1 |
| Disclosure | 82 | 1 |
| Table/Chart: Table 75 Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025 | 82 | 1 |
